Advanced BioHealing

company

About

Advanced BioHealing develops regenerative medicine solutions and commercializes cell-based and tissue-engineered products.

  • 501 - 1000

Details

Last Funding Type
Series C
Last Funding Money Raised
$25.50M
Industries
Biotechnology,Medical,Pharmaceutical
Founded date
Jan 1, 2003
Number Of Employee
501 - 1000
Operating Status
Active

Advanced BioHealing is an industry leader in the science of regenerative medicine. The Company is focused on the commercialization of cell-based and tissue-engineered products. It currently markets the FDA-approved product Dermagraft®, for diabetic foot ulcers. Additionally, the Company's development pipeline includes a next-generation bioengineered tissue product which is in clinical trials. ABH is a privately held company with research & development offices in New York, NY and manufacturing operations in La Jolla, CA.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$25.50M
Advanced BioHealing has raised a total of $25.50M in funding over 2 rounds. Their latest funding was raised on Feb 27, 2007 from a Series C round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Feb 27, 2007 Series C $25.50M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
Advanced BioHealing is funded by 1 investors. Channel Medical Partners are the most recent investors.
Investor Name Lead Investor Funding Round
Channel Medical Partners Series C